JAMY D ARD

Allopathic & Osteopathic Physicians|Internal Medicine WINSTON SALEM, NC NPI 1184679441

General Payments — all program years on this page

$256,201.84

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 258
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $39,507.84 across 30 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Regeneron Pharmaceuticals, Inc. $12,567.508
Novo Nordisk AS $11,679.068
Eli Lilly and Company $7,948.8711
Amgen Inc. $5,215.001
Novo Nordisk AS $1,500.001
Boehringer Ingelheim Pharmaceuticals, Inc. $597.411

By program year

Program yearAmountRecords
2018 $12,592.909
2019 $56,580.0362
2020 $10,945.7922
2021 $34,270.0933
2022 $63,984.1847
2023 $38,321.0155
2024 $39,507.8430

Records — PY2024 (30)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096552093 Novo Nordisk AS $1,500.00 10/21/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1096716029 Novo Nordisk Inc $483.99 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096798195 Novo Nordisk Inc $645.22 05/08/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1096879499 Novo Nordisk Inc $734.60 05/08/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1097086647 Novo Nordisk Inc $225.00 05/08/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1097198327 Novo Nordisk Inc $121.50 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097422219 Novo Nordisk Inc $1,312.50 01/01/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1097493903 Novo Nordisk Inc $7,406.25 05/08/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1097496361 Novo Nordisk Inc $750.00 05/07/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1114396098 Regeneron Pharmaceuticals, Inc. $1,848.00 03/01/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1114396100 Regeneron Pharmaceuticals, Inc. $616.00 03/01/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1114396102 Regeneron Pharmaceuticals, Inc. $1,232.00 03/01/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1114396104 Regeneron Pharmaceuticals, Inc. $4,620.00 03/01/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1114396106 Regeneron Pharmaceuticals, Inc. $2,464.00 03/01/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1114396108 Regeneron Pharmaceuticals, Inc. $715.00 06/24/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1114396110 Regeneron Pharmaceuticals, Inc. $357.50 07/12/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1114396112 Regeneron Pharmaceuticals, Inc. $715.00 12/13/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1117496320 Amgen Inc. $5,215.00 08/20/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1117907516 Boehringer Ingelheim Pharmaceuticals, Inc. $597.41 12/11/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1134998484 Eli Lilly and Company $93.87 06/02/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1134998486 Eli Lilly and Company $11.79 07/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135025876 Eli Lilly and Company $93.87 06/02/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1135025878 Eli Lilly and Company $737.51 06/02/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1135025880 Eli Lilly and Company $2,625.00 09/26/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1135043558 Eli Lilly and Company $299.60 06/02/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1135048502 Eli Lilly and Company $20.24 07/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135048504 Eli Lilly and Company $161.39 07/29/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1135048506 Eli Lilly and Company $2,625.00 05/22/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1135049528 Eli Lilly and Company $299.60 06/02/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1135049530 Eli Lilly and Company $981.00 07/29/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.